Serum miR-182 is a predictive biomarker for dichotomization of risk of hepatocellular carcinoma in rats

Merricka C. Livingstone, Natalie M. Johnson, Bill D. Roebuck, Thomas W. Kensler, John D. Groopman

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Serum miR-182 is a predictive biomarker for dichotomization of risk of hepatocellular carcinoma in rats'. Together they form a unique fingerprint.

Medicine & Life Sciences